Mesters, R M <br/><br/>
Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia.  [electronic resource] 

 -  Blood  Jul 2001 
 - 241-3 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood.v98.1.241  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Angiogenesis Inhibitors--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Bone Marrow Cells--chemistry<br/>Endothelium, Vascular--chemistry<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Indoles--administration & dosage<br/>Leukemia, Myeloid--drug therapy<br/>Middle Aged<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrroles--administration & dosage<br/>Receptor Protein-Tyrosine Kinases--drug effects<br/>Receptors, Growth Factor--drug effects<br/>Receptors, Vascular Endothelial Growth Factor<br/>Remission Induction--methods